Xencor Inc/ US98401F1057 /
| 2024-04-25 10:00:00 PM | Chg. +0.2100 | Volume | Bid10:07:23 PM | Ask10:07:23 PM | High | Low |
|---|---|---|---|---|---|---|
| 19.2300USD | +1.10% | 490,946 Turnover: 6.49 mill. |
19.0500Bid Size: 1,000 | 19.7500Ask Size: 1,000 | 19.7400 | 18.3200 |
GlobeNewswire
2023-12-04
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business ...
GlobeNewswire
2023-10-03
Vir Biotechnology Awarded BARDA Funding to Support Development of Antibody Platform Technologies for...
GlobeNewswire
2023-09-05
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to...
GlobeNewswire
2022-03-25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2022-03-03
INmune Bio, Inc. Announces Fourth Quarter and Full Year 2021 Results and Provides Business Update
GlobeNewswire
2022-03-01
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corpor...
GlobeNewswire
2022-02-10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
2022-01-13
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration o...
GlobeNewswire
2022-01-11
GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply ...
GlobeNewswire
2021-12-31
Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immun...
GlobeNewswire
2021-12-17
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatme...
GlobeNewswire
2021-12-14
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...
GlobeNewswire
2021-12-07
Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutation...
GlobeNewswire
2021-11-22
Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
GlobeNewswire
2021-11-17
Sarepta Therapeutics Appoints Stephen L. Mayo, Ph.D., to its Board of Directors
GlobeNewswire
2021-11-15
CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors
GlobeNewswire
2021-11-03
INmune Bio, Inc. Announces Third Quarter 2021 Results and Provides Business Update
GlobeNewswire
2021-08-04
INmune Bio, Inc. Announces Second Quarter 2021 Results and Provides Business Update
GlobeNewswire
2021-08-02
Arch Oncology Strengthens Medical and Clinical Leadership Teams with Key Appointments
GlobeNewswire
2021-06-14
INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce Future Di...
GlobeNewswire
2021-03-25
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
GlobeNewswire
2021-03-23
Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Deve...
GlobeNewswire
2021-02-24
CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
